Developing in vivo CAR T-cell therapies requires reliable approaches for transient, controlled CAR expression and targeted mRNA delivery to immune cells. This webinar will examine the transformative ...

While the 2025-2030 Dietary Guidelines for Americans (DGA) reinforces existing priorities rather than upend them, for ...

An Oxford Global event designed to connect stakeholders across early-stage R&D—from target discovery and lead optimisation ...

The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course (May 7, 2026)" has been added to ResearchAndMarkets.com's offering. Understanding the ...

DHAKA, Jan 15, 2026 (BSS)- The Ministry of Youth and Sports today signed a tripartite performance agreement with Plan ...

Bio?Sourcing and Zerion Pharma A/S today announce that their joint project to develop an oral formulation of Trastuzumab, the pioneer monoclonal antibody used to treat breast cancer, has been awarded ...

Persist AI is a drug formulation technology company that developed artificial intelligence-powered Cloud Lab, a remote, cloud ...

Bio-Sourcing and Zerion Pharma have obtained a €1.3 million EU grant reward under the Eurostars program to advance an orally administered anti-HER2, antibody Trastuzimab, for treatment of breast cance ...

Doseology Sciences Inc. (CSE: MOOD) (PINK: DOSEF) (FSE: VU70) ("Doseology" or the "Company") a leader in biotechnology-driven ...

Mandara Biopharma Inc., a privately held U.S.-based biopharmaceutical company focused on novel therapies for central nervous system (CNS) disorders, today announced that it has filed an ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...